skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 5,638  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Refined by: Database: DOAJ Directory of Open Access Journals remove Database: ProQuest One Psychology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
The short-term health and economic burden of gestational diabetes mellitus in China: a modelling study
The short-term health and economic burden of gestational diabetes mellitus in China: a modelling study
Material Type:
Article 		Add to My Research

The short-term health and economic burden of gestational diabetes mellitus in China: a modelling study

BMJ open, 2017-12, Vol.7 (12), p.e018893-e018893 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2017 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2017-018893 ;PMID: 29203507

Full text available

Citations Cited by
22
Direct healthcare cost of schizophrenia – European overview
Direct healthcare cost of schizophrenia – European overview
Material Type:
Article 		Add to My Research

Direct healthcare cost of schizophrenia – European overview

European psychiatry, 2018-02, Vol.48 (1), p.79-92 [Peer Reviewed Journal]

2017 Elsevier Masson SAS ;Copyright © 2017 Elsevier Masson SAS. All rights reserved. ;ISSN: 0924-9338 ;EISSN: 1778-3585 ;DOI: 10.1016/j.eurpsy.2017.10.008 ;PMID: 29428166

Digital Resources/Online E-Resources

Citations Cited by
23
Comparative cost analysis of inpatient integrative medicine—Results of a pilot study
Comparative cost analysis of inpatient integrative medicine—Results of a pilot study
Material Type:
Article 		Add to My Research

Comparative cost analysis of inpatient integrative medicine—Results of a pilot study

Complementary therapies in medicine, 2017-06, Vol.32, p.129-133 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2017 ;ISSN: 0965-2299 ;EISSN: 1873-6963 ;DOI: 10.1016/j.ctim.2016.11.009 ;PMID: 28619299

Full text available

Citations Cited by
24
Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocol
Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocol
Material Type:
Article 		Add to My Research

Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocol

BMJ open, 2024-05, Vol.14 (5), p.e080510-e080510 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-080510 ;PMID: 38692717

Full text available

Citations Cited by
25
Evaluating possible intended and unintended consequences of the implementation of alcohol minimum unit pricing (MUP) in Scotland: a natural experiment protocol
Evaluating possible intended and unintended consequences of the implementation of alcohol minimum unit pricing (MUP) in Scotland: a natural experiment protocol
Material Type:
Article 		Add to My Research

Evaluating possible intended and unintended consequences of the implementation of alcohol minimum unit pricing (MUP) in Scotland: a natural experiment protocol

BMJ open, 2019-06, Vol.9 (6), p.e028482-e028482 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-028482 ;PMID: 31221890

Full text available

Citations Cited by
26
Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol
Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol
Material Type:
Article 		Add to My Research

Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol

BMJ open, 2019-07, Vol.9 (7), p.e027922 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-027922 ;PMID: 31270115

Full text available

Citations Cited by
27
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Material Type:
Article 		Add to My Research

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

BMC psychiatry, 2022-04, Vol.22 (1), p.250-250, Article 250 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-244X ;EISSN: 1471-244X ;DOI: 10.1186/s12888-022-03895-2 ;PMID: 35395757

Full text available

Citations Cited by
28
Economic evaluation of return-to-work interventions for mental disorder-related sickness absence: two years follow-up of a randomized clinical trial
Economic evaluation of return-to-work interventions for mental disorder-related sickness absence: two years follow-up of a randomized clinical trial
Material Type:
Article 		Add to My Research

Economic evaluation of return-to-work interventions for mental disorder-related sickness absence: two years follow-up of a randomized clinical trial

Scandinavian journal of work, environment & health, 2022-05, Vol.48 (4), p.264-272 [Peer Reviewed Journal]

Copyright Scandinavian Journal of Work, Environment & Health 2022 ;ISSN: 0355-3140 ;ISSN: 1795-990X ;EISSN: 1795-990X ;DOI: 10.5271/sjweh.4012 ;PMID: 35094095

Full text available

Citations Cited by
29
Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits
Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits
Material Type:
Article 		Add to My Research

Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits

BMC psychiatry, 2019-08, Vol.19 (1), p.240-240, Article 240 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-244X ;EISSN: 1471-244X ;DOI: 10.1186/s12888-019-2223-3 ;PMID: 31382932

Full text available

Citations Cited by
30
A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015
A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015
Material Type:
Article 		Add to My Research

A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015

BMJ open, 2017-10, Vol.7 (10), p.e018289-e018289 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2017 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2017-018289 ;PMID: 29061629

Full text available

Citations Cited by
31
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
Material Type:
Article 		Add to My Research

Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

BMJ open, 2014-07, Vol.4 (7), p.e005094-e005094 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2014-005094 ;PMID: 25079928

Full text available

Citations Cited by
32
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity
Material Type:
Article 		Add to My Research

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity

Journal of headache and pain, 2024-04, Vol.25 (1), p.59-59 [Peer Reviewed Journal]

The Author(s) 2024 ;2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1129-2369 ;EISSN: 1129-2377 ;DOI: 10.1186/s10194-024-01749-8 ;PMID: 38637754

Full text available

Citations Cited by
33
Harms and costs of proposed changes in how alcohol is sold in Ontario
Harms and costs of proposed changes in how alcohol is sold in Ontario
Material Type:
Article 		Add to My Research

Harms and costs of proposed changes in how alcohol is sold in Ontario

Canadian Medical Association journal (CMAJ), 2024-04, Vol.196 (13), p.E447-E448 [Peer Reviewed Journal]

COPYRIGHT 2024 CMA Impact Inc. ;Copyright CMA Impact, Inc. Apr 8, 2024 ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.240069 ;PMID: 38589028

Full text available

Citations Cited by
34
Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)
Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)
Material Type:
Article 		Add to My Research

Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial)

BMJ open, 2018-02, Vol.8 (2), p.e018640-e018640 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2017-018640 ;PMID: 29449292

Full text available

Citations Cited by
35
Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
Material Type:
Article 		Add to My Research

Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis

BMC psychiatry, 2017-06, Vol.17 (1), p.222-222, Article 222 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-244X ;EISSN: 1471-244X ;DOI: 10.1186/s12888-017-1385-0 ;PMID: 28629442

Full text available

Citations Cited by
36
A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom
A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom
Material Type:
Article 		Add to My Research

A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom

Comprehensive psychiatry, 2023-11, Vol.127, p.152422-152422, Article 152422 [Peer Reviewed Journal]

2023 ;Copyright Elsevier Limited Nov 2023 ;ISSN: 0010-440X ;EISSN: 1532-8384 ;DOI: 10.1016/j.comppsych.2023.152422

Full text available

Citations Cited by
37
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
Material Type:
Article 		Add to My Research

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD

BMC psychiatry, 2016-01, Vol.16 (11), p.11-11, Article 11 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;Lachaine et al. 2016 ;ISSN: 1471-244X ;EISSN: 1471-244X ;DOI: 10.1186/s12888-016-0708-x ;PMID: 26774811

Full text available

Citations Cited by
38
Estimating the costs of the national basic public health services in Zhuhai, China, through activity-based costing: a cross-sectional study
Estimating the costs of the national basic public health services in Zhuhai, China, through activity-based costing: a cross-sectional study
Material Type:
Article 		Add to My Research

Estimating the costs of the national basic public health services in Zhuhai, China, through activity-based costing: a cross-sectional study

BMJ open, 2019-06, Vol.9 (6), p.e024831-e024831 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-024831 ;PMID: 31256019

Full text available

Citations Cited by
39
The labor market costs of work-related stress: A longitudinal study of 52 763 Danish employees using multi-state modeling
The labor market costs of work-related stress: A longitudinal study of 52 763 Danish employees using multi-state modeling
Material Type:
Article 		Add to My Research

The labor market costs of work-related stress: A longitudinal study of 52 763 Danish employees using multi-state modeling

Scandinavian journal of work, environment & health, 2024-03, Vol.50 (2), p.61-72 [Peer Reviewed Journal]

Copyright Scandinavian Journal of Work, Environment & Health 2024 ;Copyright: © Scandinavian Journal of Work, Environment & Health 2024 ;ISSN: 0355-3140 ;EISSN: 1795-990X ;DOI: 10.5271/sjweh.4131 ;PMID: 37943108

Full text available

Citations Cited by
40
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
Material Type:
Article 		Add to My Research

Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

BMJ open, 2016-04, Vol.6 (4), p.e011063-e011063 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2016-011063 ;PMID: 27130167

Full text available

Citations Cited by

Results 21 - 40 of 5,638  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1984  (32)
  2. 1984 To 1993  (150)
  3. 1994 To 2003  (443)
  4. 2004 To 2014  (1,092)
  5. After 2014  (3,922)
  6. More options open sub menu

Subject 

  1. Science & Technology  (4,847)
  2. Life Sciences & Biomedicine  (4,837)
  3. Humans  (3,671)
  4. General & Internal Medicine  (3,278)
  5. Medicine, General & Internal  (3,278)
  6. Female  (1,551)
  7. Patients  (1,377)
  8. Cost Analysis  (1,304)
  9. Male  (1,300)
  10. Cost-Benefit Analysis  (1,281)
  11. Adult  (1,139)
  12. Costs  (1,080)
  13. Quality Of Life  (1,009)
  14. Middle Aged  (869)
  15. Intervention  (858)
  16. Psychiatry  (842)
  17. Public Health  (830)
  18. Health Economics  (820)
  19. Aged  (785)
  20. Hospitals  (683)
  21. More options open sub menu

Language 

  1. English  (5,602)
  2. Japanese  (151)
  3. Polish  (27)
  4. Italian  (26)
  5. Portuguese  (26)
  6. French  (24)
  7. Norwegian  (13)
  8. Spanish  (8)
  9. German  (5)
  10. Swedish  (4)
  11. Danish  (4)
  12. Turkish  (4)
  13. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait